Limitations, agreements, and source contact

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy · Source last updated 2015-11-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

point Of Contact

email

barlogiebart@uams.edu

organization

UAMS Myeloma Institute

phone

501-526-6990

phone Ext

2420

title

Bart Barlogie

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice